Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
58.86
-0.63 (-1.05%)
May 13, 2026, 11:40 AM EDT - Market open

KNSA Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
754.05677.56423.24270.26220.1838.54
Revenue Growth (YoY)
56.71%60.09%56.61%22.75%471.24%-
Cost of Revenue
80.677.6760.9133.4122.99.1
Gross Profit
673.44599.89362.33236.85197.2929.44
Selling, General & Admin
213.89196.27168.01129.4397.9585.95
Research & Development
10596.85111.6276.165.4999.3
Other Operating Expenses
261.33229.55128.3156.5224.070.84
Total Operating Expenses
580.23522.67407.95262.05187.51186.08
Operating Income
93.2277.22-45.62-25.29.77-156.64
Total Non-Operating Income (Expense)
12.7711.659.468.541.250.1
Pretax Income
105.9888.87-36.15-16.6511.03-156.54
Provision for Income Taxes
-32.93-29.86-7.0430.74172.34-1.39
Net Income
73.0659.01-43.1914.08183.36-157.92
Net Income to Common
73.0659.01-43.1914.08183.36-157.92
Net Income Growth
----92.32%--
Shares Outstanding (Basic)
757471706969
Shares Outstanding (Diluted)
807971727069
Shares Change (YoY)
10.56%10.58%-0.69%2.13%2.69%10.89%
EPS (Basic)
0.980.80-0.600.202.64-2.30
EPS (Diluted)
0.900.75-0.600.202.60-2.30
EPS Growth
----92.31%--
Shares Outstanding
76.6976.2972.5270.4669.769.06
Free Cash Flow
164.23136.4225.4113.175.7-126.71
Free Cash Flow Growth
20.39%436.82%92.94%130.99%--
Free Cash Flow Per Share
2.041.730.360.180.08-1.85
Gross Margin
89.31%88.54%85.61%87.64%89.60%76.39%
Operating Margin
12.36%11.40%-10.78%-9.32%4.44%-406.38%
Profit Margin
9.69%8.71%-10.21%5.21%83.28%-409.72%
FCF Margin
21.78%20.13%6.00%4.87%2.59%-328.75%
EBITDA
94.8978.78-43.92-22.8612.18-154.28
EBITDA Margin
12.58%11.63%-10.38%-8.46%5.53%-400.27%
EBIT
93.2277.22-45.62-25.29.77-156.64
EBIT Margin
12.36%11.40%-10.78%-9.32%4.44%-406.38%
Effective Tax Rate
-31.07%-33.60%19.48%-184.58%1563.01%0.88%
Updated Apr 28, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q